Assessment of AlbuSure and its usefulness in identifying IDDM subjects at increased risk for developing clinical diabetic nephropathy.

MLA

Coonrod, Beth A., et al. “Assessment of AlbuSure and Its Usefulness in Identifying IDDM Subjects at Increased Risk for Developing Clinical Diabetic Nephropathy.” Diabetes Care, vol. 12, no. 6, June 1989, pp. 389–93. EBSCOhost, https://doi.org/10.2337/diacare.12.6.389.

APA

Coonrod, B. A., Ellis, D., Becker, D. J., Dorman, J. S., Drash, A. L., Kuller, L. H., Orchard, T. J., Coonrod, B. A., Ellis, D., Becker, D. J., Dorman, J. S., Drash, A. L., Kuller, L. H., & Orchard, T. J. (1989). Assessment of AlbuSure and its usefulness in identifying IDDM subjects at increased risk for developing clinical diabetic nephropathy. Diabetes Care, 12(6), 389–393. https://doi.org/10.2337/diacare.12.6.389

Chicago

Coonrod, Beth A., Demetriu Ellis, Dorothy J. Becker, Janice S. Dorman, Allan L. Drash, Lewis H. Kuller, Trevor J. Orchard, et al. 1989. “Assessment of AlbuSure and Its Usefulness in Identifying IDDM Subjects at Increased Risk for Developing Clinical Diabetic Nephropathy.” Diabetes Care 12 (6): 389–93. doi:10.2337/diacare.12.6.389.